Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;80(1):73-78.
doi: 10.1007/s40265-019-01250-6.

Cenobamate: First Approval

Affiliations
Review

Cenobamate: First Approval

Susan J Keam. Drugs. 2020 Jan.

Abstract

Cenobamate (XCOPRI®) is an oral, small molecule neurotherapeutic azole compound that is being developed by SK Life Science Inc. and Arvelle Therapeutics for the treatment of epilepsy. Based on results of two pivotal phase 2 trials, cenobamate was recently approved in the USA for use in the treatment of partial-onset seizures in adult patients. This article summarizes the milestones in the development of cenobamate leading to this first approval.

PubMed Disclaimer

References

    1. Eur J Pharmacol. 2019 Jul 15;855:175-182 - PubMed
    1. Neurology. 2019 Aug 6;93(6):e559-e567 - PubMed
    1. Lancet Neurol. 2020 Jan;19(1):38-48 - PubMed

LinkOut - more resources